Purpose: To evaluate biofilm inhibiting activity of depolymerase enzyme extracted from STEC specific phage.
Methods: Previously sequenced phages, isolated in the lab, were tested for the presence of depolymerase-enzyme-coding gene in STEC-O45 using homologous sequence alignment tool (BLAST), PCR and gel electrophoresis. Crude depolymerase-enzyme was extracted using phage-lysate, centrifugation, dialysis, PEG concentration, and ultracentrifugation. Crude extract was then tested for inhibition against STEC-O45, using spot-on-lawn assay. Additionally, its biofilm disrupting capabilities were examined by allowing STEC-O45 (7 log10 CFU/ml) to form biofilms in micro-titer plates for 24 hrs. Plates were then treated with phage, phage-depolymerase or PBS-control for 16 hrs and stained with crystal-violet. Biofilm disruption was measured as a change in absorbance (A595) and was visually analyzed with Scanning Electron Microscopy (SEM). Surviving bacterial population was also enumerated on tryptic soy agar.
Results: Sequences homologous to phage-enzyme were used to design primers. The presence of enzyme-encoding sequence in the phage was confirmed by PCR-positive band at ~800bp. Crude phage-enzyme extract showed lytic activity against STEC-O45 on spot-on-lawn assay. Phage and phage-enzyme treated wells showed reduction in absorbance (0.705 to 0.918) of STEC biofilms, compared to control. A reduction of 1.0-1.1 logs in STEC population was observed with phage and phage-depolymerase treatments. SEM images showed an extracellular matrix surrounding the colonies in PBS-control. However, phage and phage-depolymerase treated cells showed rough surfaces with filament-like cell envelopes, indicating cellular damage.
Significance: Bacteriophage and phage-depolymerase can be applied as bio-control agents in the food industry to control STEC biofilms.